BICXBioCorRx Inc.vs its industry peers
A metric-by-metric comparison of BioCorRx Inc. against Services-Specialty Outpatient Facilities, NEC — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BICXThis | — | — | — | — | 10301.1%#1 | 32.6%#1 | -606.0%#4 | — | — | 4#1 | — | — |
| ACHC | $2.9B#2 | — | 1.5x#1 | 0.9x#1 | 5.0%#3 | -531.4%#4 | 17.7%#1 | -56.3%#2 | 13.5%#1 | — | 73.2%#1 | — |
| CON | $3.9B#1 | 19.8x#1 | 8.2x#2 | 1.8x#2 | 13.9%#2 | -0.1%#2 | 15.4%#2 | 34.9%#1 | — | — | 52.9%#2 | 0.8%#1 |
| EHSI | — | — | — | — | — | -279.8%#3 | -374.9%#3 | -192.2%#3 | -66.7%#2 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 8093). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-08-07.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice